Friday 25 September 2026
Internal Reference Number: FOI_9450
Date Request Received: 10/06/2026 00:00:00
Date Request Replied To: 24/06/2026 00:00:00
This response was sent via: By Email
Request Summary: Drug supply issues
Request Category: Private Individuals
| Question Number 1: Under the Freedom of Information Act 2000, I would like to request the following information relating to the following - The supply disruption affecting prescription co-codamol, particularly 30mg/500mg tablets and capsules. The supply and availability of aspirin (all licensed doses used therapeutically) within your Trust. The supply and availability of ramipril (all strengths) within your Trust. Current Stock and Usage • What is the current stock level of co-codamol in 30mg/500mg tablets held by your Trust (by number of tablets/capsules and number of packs)? • What is the current stock level of aspirin held by your Trust (by number of tablets and number of packs)? • What is the current stock level of ramipril held by your Trust (by number of tablets/capsules and number of packs)? • What is your Trust's monthly dispensing or usage volume of co-codamol 30mg/500mg since March 2025 to present? • What is your Trust's monthly dispensing or usage volume of aspirin since May 2025 to present? • What is your Trust's monthly dispensing or usage volume of ramipril since May 2025 to present? | |
| Answer To Question 1: Please see attached Q1-3 answers To accompany this answer to question 1 please also see the documents listed below:  FOI-9450 - Q1-3.pdf | |
| Question Number 2: Supply Disruption and Patient Impact • Has your Trust experienced any disruption to the supply of co-codamol 30mg/500mg in the past three years (2022–2025)? If yes, please provide: the date(s) the disruption was first encountered, the approximate duration, and which formulations were affected. • Has your Trust experienced any disruption to the supply of aspirin in the past three years (2022–2025)? If yes, please provide: the date(s) the disruption was first encountered, the approximate duration, and which formulations were affected. • Has your Trust experienced any disruption to the supply of ramipril in the past three years (2022–2025)? If yes, please provide: the date(s) the disruption was first encountered, the approximate duration, and which strengths were affected. • Has the supply disruption required your Trust to switch patients to alternative analgesics? If yes, please state which alternatives were prescribed and the number of patients affected. • Has the supply disruption required your Trust to switch patients to alternative medications? If yes, please state which alternatives were prescribed and the number of patients affected. • Has your Trust raised any formal incident reports internally or with NHS England/NHS Supply Chain as a result of this supply issue? If yes, how many in the past 12 months? | |
| Answer To Question 2: Has your Trust raised any formal incident reports internally or with NHS England/NHS Supply Chain as a result of this supply issue? If yes, how many in the past 12 months? - Less than 5. | |
| Question Number 3: Stockpiling and Contingency • Does your Trust hold a formal contingency or safety stock policy for co-codamol 30mg/500mg? If yes, please provide the minimum stock threshold. • Does your Trust hold a formal contingency or safety stock policy for aspirin? If yes, please provide the minimum stock threshold. • Does your Trust hold a formal contingency or safety stock policy for ramipril? If yes, please provide the minimum stock threshold. • Has your Trust increased stock levels of co-codamol 30mg/500mg as a precautionary measure in the past 12 months? • Has your Trust increased stock levels of aspirin as a precautionary measure in the past 12 months? • Has your Trust increased stock levels of ramipril as a precautionary measure in the past 12 months? • If yes, by how many units did you increase stock levels for each? | |
| Answer To Question 3: Please see attachment | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
